PRESS RELEASE published on 04/16/2023 at 17:00, 1 year 7 months ago Moderna and Merck Announce mRNA-4157 (V940), an Investigational Individualized Neoantigen Therapy, in Combination with KEYTRUDA(R) (Pembrolizumab), Demonstrated Superior Recurrence-Free Survival in Patients with High-Risk Stage III/IV Melanoma Following C
PRESS RELEASE published on 04/11/2023 at 13:00, 1 year 7 months ago Moderna Announces Clinical and Program Updates at 4th Vaccines Day
PRESS RELEASE published on 04/06/2023 at 23:00, 1 year 7 months ago MRNA-4157/V940, an Investigational Personalized MRNA Cancer Vaccine, in Combination With Keytruda(R) (Pembrolizumab), Receives Prime Scheme Designation From the European Medicines Agency for Adjuvant Treatment of Patients With High-Risk Stage III/IV Melan
PRESS RELEASE published on 03/30/2023 at 13:00, 1 year 7 months ago Moderna Finalizes Agreement with the Government of the Republic of Kenya to Establish an mRNA Manufacturing Facility
PRESS RELEASE published on 03/24/2023 at 12:30, 1 year 8 months ago Moderna to Host Fourth Annual Virtual Vaccines Day on April 11, 2023
PRESS RELEASE published on 03/23/2023 at 12:02, 1 year 8 months ago Moderna and Generation Bio Announce Strategic Collaboration to Develop Non-Viral Genetic Medicines
PRESS RELEASE published on 03/14/2023 at 22:40, 1 year 8 months ago Moderna Announces Phase 2 Data on mRNA-4157/V940, an Investigational mRNA Personalized Cancer Vaccine, to be Presented at the 2023 AACR Annual Meeting
PRESS RELEASE published on 03/10/2023 at 17:00, 1 year 8 months ago Moderna Outlines Commitment to Corporate Growth and Announces U.S. Expansion in 2023
PRESS RELEASE published on 02/28/2023 at 13:30, 1 year 8 months ago Moderna to Present at Cowen's 43rd Annual Health Care Conference
PRESS RELEASE published on 02/23/2023 at 13:00, 1 year 9 months ago Moderna Reports Fourth Quarter and Fiscal Year 2022 Financial Results and Provides Business Updates
Published on 11/25/2024 at 23:00, 23 minutes ago Logo Brands Signs Historic Partnership With Jackson State University
Published on 11/25/2024 at 22:15, 1 hour 8 minutes ago CoTec Holdings Corp. Announces Convertible Loan Agreement
Published on 11/25/2024 at 20:45, 2 hours 38 minutes ago Tecogen Receives Orders for 12 Cogeneration Systems
Published on 11/25/2024 at 20:00, 3 hours 23 minutes ago The Official VHA-H: Hoverfly Spectre Secures Variable Height Antenna - Heavy (VHA-H) Program for U.S. Army
Published on 11/25/2024 at 20:35, 2 hours 48 minutes ago Launch of World Advanced Manufacturing & Logistics Expo & Summit (WAM Morocco) 2025 to Advance the Country’s Shift Towards Next-Generation Industries and High-Value Manufacturing
Published on 11/25/2024 at 20:35, 2 hours 48 minutes ago World Advanced Manufacturing & Logistics Expo & Summit (WAM Morocco) 2025 : Le Maroc se positionne comme leader des industries de nouvelle génération
Published on 11/25/2024 at 20:34, 2 hours 48 minutes ago Avolta wins new ten-year contract, adds Manaus Airport to Brazil portfolio
Published on 11/25/2024 at 19:00, 4 hours 23 minutes ago PATRIMOINE ET COMMERCE: Déclaration des transactions sur actions propres (Hors contrat de liquidité) réalisées du 18 NOVEMBRE 2024 au 22 NOVEMBRE 2024
Published on 11/25/2024 at 18:55, 4 hours 28 minutes ago Molten Ventures Plc: HOL-Holding(s) in Company
Published on 11/25/2024 at 18:00, 5 hours 23 minutes ago Chiffre d’affaires consolidé 2023-2024 : 91 M€ en repli de 9,4 %
Published on 11/25/2024 at 17:55, 5 hours 28 minutes ago Déclaration des transactions sur actions propres réalisées du 18/11/2024 au 22/11/2024
Published on 11/25/2024 at 17:55, 5 hours 28 minutes ago Disclosure of trading in own shares from 18/11/2024 to 22/11/2024
Published on 11/25/2024 at 17:45, 5 hours 38 minutes ago Reporting on share buyback transactions carried out between November 19 and November 22, 2024
Published on 11/25/2024 at 17:45, 5 hours 38 minutes ago Déclaration de rachats d'actions effectués par la Compagnie de Saint-Gobain entre le 19 et le 22 novembre 2024
